Fuso Pharmaceutical Industries,Ltd.

Tokyo Stock Exchange 4538.T

Fuso Pharmaceutical Industries,Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -23.36 M

Fuso Pharmaceutical Industries,Ltd. Net Cash Used For Investing Activities is USD -23.36 M for the year ending March 31, 2024, a -126.06% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Fuso Pharmaceutical Industries,Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -10.33 M, a 18.99% change year over year.
Fuso Pharmaceutical Industries,Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -12.76 M, a -44.46% change year over year.
Fuso Pharmaceutical Industries,Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -8.83 M, a 36.05% change year over year.
Fuso Pharmaceutical Industries,Ltd. Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -13.81 M, a 35.37% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Tokyo Stock Exchange: 4538.T

Fuso Pharmaceutical Industries,Ltd.

CEO	Mr. Mikio Toda
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-7-10, Doshomachi
Employees	1,370
Sector	Consumers Staples
Industries Cleaning Supplies Automotive Parts Composite Materials Hardware & Electronics Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

Key trends

Past 5 years